Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Isaakidis, Petros ^a   Paryani, Roma ^a   Khan, Samsuddin ^a   Mansoor, Homa ^a   Manglani, Mamta ^b   Valiyakath, Asmaa ^a   Saranchuk, Peter ^a   Furin, Jennifer ^c  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS LOPINAVIR PLUS RITONAVIR; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIRETROVIRUS AGENT; ATAZANAVIR PLUS LAMIVUDINE PLUS RITONAVIR PLUS TENOFOVIR; CAPREOMYCIN; CLOFAZIMINE; CYCLOSERINE; EFAVIRENZ PLUS LAMIVUDINE PLUS STAVUDINE; EFAVIRENZ PLUS LAMIVUDINE PLUS TENOFOVIR; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LEVOFLOXACIN; MOXIFLOXACIN; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OFLOXACIN; PROTEINASE INHIBITOR; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STREPTOMYCIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONVULSION; DRUG MEGADOSE; DRUG WITHDRAWAL; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GASTROINTESTINAL INTOLERANCE; GASTROINTESTINAL SYMPTOM; HEARING IMPAIRMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOKALEMIA; HYPOTHYROIDISM; INDIA; LUNG TUBERCULOSIS; MALE; MENTAL DISEASE; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; NEPHROTOXICITY; PATIENT COMPLIANCE; PATIENT REFERRAL; PERIPHERAL NEUROPATHY; PROGNOSIS; PSYCHOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84880445868     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068869     Document Type: Article

References (37)

1. World Health Organization (2008) Anti-tuberculosis drug resistance in the world Report no. 4. Geneva, Switzerland. ISBN 978 92 4 156361 1: WHO/HTM/TB/2008.394.
2. World Health Organization (2011) Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015 Geneva, Switzerland. ISBN: 978 92 4 150133: WHO/HTM/TB/2011.3.
3. Seddon JA, Hesseling A, Willemse M, Donald PR, Schaaf HS (2011) Culture-Confirmed Multidrug-Resistant Tuberculosis in Children: Clinical Features, Treatment, and Outcomes. Clin Infect Dis. doi: 10.1093/cid/cir772.
4. Schaaf HS, (2007) Drug-resistant tuberculosis in children. S Afr Med J 97: 995-97.
5. Ettehad D, Schaaf HS, Seddon JA, Cooke GS, Ford N, (2012) Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. The Lancet Infectious Diseases. 12(6): 449-56.
6. Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, et al. (2006) Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 117(6): 2022-9.
7. Coelho Filho JC, Caribe MA, Caldas SC, Martins Netto E, (2011) Is tuberculosis difficult to diagnose in childhood and adolescence?. Jornal Brasileiro De Pneumologia: Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia. 37(3): 288-93.
8. World Health Organization (2013) Adolescent Health. http://www.who.int/topics/adolescent_health/en/. Accessed February 12, 2013.
9. Perez-Velez CM, (2012) Pediatric tuberculosis: new guidelines and recommendations. Curr Opin Pediatr. Jun 24(3): 319-28.
10. Geldenhuys H, Sorsdahl K, Kafaar F, Hatherill M, Hanekom WA, Stein DJ, et al. (2011) Risky behaviour and psychosocial correlates in adolescents- is there a link with tuberculosis?. African Journal of Psychiatry. 14(5): 383-7.
11. Greenley RN, Kunz JH, Biank V, Martinez A, Miranda A, et al. (2012) Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease. Inflammatory Bowel Diseases. 18(7): 1254-9.
12. Nichols SL, Montepiedra G, Farley JJ, Sirois PA, Malee K, et al. (2012) PACTG P1042S Team. Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection. Journal of Developmental & Behavioral Pediatrics. 33(4): 298-308.
13. Chiang CY, Bai KJ, Lee CN, Enarson DA, Suo J, et al. (2010) Inconsistent dosing of anti-tuberculosis drugs in Taipei, Taiwan.International Journal of Tuberculosis & Lung Disease. 14(7): 878-83.
14. Thampi N, Stephens D, Rea E, Kitai I, (2012) Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors. Pediatric Infectious Disease Journal. 31(2): 129-33.
15. Phongsamart W, Kitai I, Gardam M, Wang J, Khan K, (2009) A population-based study of tuberculosis in children and adolescents in Ontario. Pediatric Infectious Disease Journal. 28(5): 416-9.
16. M'imunya JM, Kredo T, Volmink J, (2012) Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database of Systematic Reviews. 5: CD006591.
17. Chandwani S, Koenig LJ, Sill AM, Abramowitz S, Conner LC, et al. (2012) Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIV. Journal of Adolescent Health. 51(3): 242-51.
18. Arnone J, Fitzsimons V, (2012) Adolescents with celiac disease: a literature review of the impact developmental tasks have on adherence with a gluten-free diet. Gastroenterology Nursing. 35(4): 248-54.
19. Hodgson I, Ross J, Haamujompa C, Gitau-Mburu D, (2012) Living as an adolescent with HIV in Zambia - lived experiences, sexual health and reproductive needs. AIDS Care. 24(10): 1204-10.
20. Fair CD, Sullivan K, Dizney R, Stackpole A, (2012) "It's like losing a part of my family": transition expectations of adolescents living with perinatally acquired HIV and their guardians. AIDS Patient Care & Stds. 26(7): 423-9.
21. Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, et al. (2011) Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India. PLoS ONE [Electronic Resource]. 6(12): e28066.
22. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Viru FA, et al. (2004) Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet. 363(9407): 474-81, 2004.
23. Isaakidis P, Varghese B, Mansoor H, Cox HS, Ladomirska J, et al. (2012) Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.PLoS ONE [Electronic Resource]. 7(7): e40781.
24. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, et al. (2010) Tugela Ferry Care and Research (TF CARES) Collaboration. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. American Journal of Respiratory & Critical Care Medicine. 181(1): 80-6.
25. Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, et al. (2012) The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Annals of Internal Medicine. 157(5): 313-24.
26. Furin JJ, Johnson JL, (2005) Recent advances in the diagnosis and management of tuberculosis. Current Opinion in Pulmonary Medicine. 11(3): 189-94.
27. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, et al. (2008) Comprehensive treatment of extensively drug-resistant tuberculosis. NewEnglandJournalofMedicine. 359(6): 563-74.
28. Chan ED, Strand MJ, Iseman MD, (2008) Treatment outcomes in extensively resistant tuberculosis. New England Journal of Medicine. 359(6): 657-9.
29. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, et al. (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine. 348(2): 119-28.
30. Farmer P, (1999) Managerial successes, clinical failures. International Journal of Tuberculosis & Lung Disease. 3(5): 365-7.
31. Sachdeva KS, Kumar A, Dewan P, Kumar A, Satyanarayana S, (2012) New vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - "reaching the un-reached". Indian Journal of Medical Research. 135(5): 690-4.
32. Fairlie L, Beylis NC, Reubenson G, Moore DP, Madhi SA, (2011) High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infectious Diseases. 11: 28.
33. Singla N, Singla R, Jain G, Habib L, Behera D, (2011) Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India. International Journal of Tuberculosis & Lung Disease. 15(10): 1326-30.
34. Errol L, Isaakidis P, Zachariah R, Ali M, Pilankar G, et al. (2012) Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India. J Adv Nurs 68(11): 2399-409.
35. Nansera D, Bajunirwe F, Elyanu P, Asiimwe C, Amanyire G, Graziano FM, (2012) Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda. International Journal of Tuberculosis & Lung Disease. 16(10): 1371-6.
36. Garrido Mda S, Penna ML, Perez-Porcuna TM, de Souza AB, Marreiro Lda S, et al. (2012) Factors associated with tuberculosis treatment default in an endemic area of the Brazilian Amazon: a case control-study.PLoS ONE [Electronic Resource]. 7(6): e39134.
37. Maruza M, Albuquerque MF, Coimbra I, Moura LV, Montarroyos UR, et al. (2011) Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study.BMC Infectious Diseases. 11: 351.